Furthermore, mice receiving Drd3−/− OT-I transgenic CD8+ T-cells showed faster tumour growth, compared with those receiving Drd3+/+ OT-I transgenic CD8+ T-cells (Figure 5B,C). Here, CD8A is linked to neoplasm.